amount of financial allocation is required if all sick persons of India would have full access to rational treatment for …

, India - presents results of a sample survey (1982-1983) of energy use (incl. Private sector transport) in eight communitys …

25 years. In India, today about 10 million people are pushed below the poverty line annually because of unaffordable … pay the hospital bill. This situation of spread of new diseases due to environmental or socio-cultural degradation and the …

innovation—using data on over one million hospital discharges. …Assessing the benefits of medical innovation—its impact on health outcomes—is as important as assessing the costs … that investigates the benefits and costs of another broad category of medical innovation—inpatient therapeutic procedure …

We investigate the impact of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey …

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … death), hospital utilization, and medical expenditure in Greece during the period 1995-2010. The estimates indicate that … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months)-—about 44% of the total increase in longevity …

in services. The goal of this paper is to highlight the place of PPPs in innovation dynamics in hospitals by mobilizing … and applying theoretical models of innovation in services to an in-depth case study of a complex innovation-oriented PPP …. This is about uncovering the multifaceted nature of innovation in hospitals involved in PPPs at inter …

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … death) and medical expenditure in France during the period 2000–2009. The estimates imply that pharmaceutical innovation …